Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States

Clinical Management of Hospitalized Coronavirus Disease 2019 Patients in the United States

Background: The objective of this study was to characterize hospitalized coronavirus disease 2019 (COVID-19) patients and describe their real-world treatment patterns and outcomes over time. Methods: Adult patients hospitalized on May 1, 2020-December 31, 2020 with a discharge diagnosis of COVID-19...

Full description

Bibliographic Details
Main Authors: Casciano, R. (Author), Chandak, A. (Author), Gayle, J. (Author), Gottlieb, R.L (Author), Haubrich, R. (Author), Hodgkins, P. (Author), Kuritzkes, D.R (Author), Liang, S. (Author), Mozaffari, E. (Author), Sax, P.E (Author), Thrun, M. (Author), Wohl, D.A (Author), Zhang, Z. (Author)
Format: Article
Language:English
Published: Oxford University Press 2022
Subjects:
adult
aged
all cause mortality
Article
artificial ventilation
azithromycin
baricitinib
clinical management
cohort analysis
convalescent plasma
coronavirus disease 2019
COVID-19
dexamethasone
extracorporeal oxygenation
female
hospital mortality
hospitalization
human
hydroxychloroquine
ICD-10
ICD-9
intensive care unit
intermittent mandatory ventilation
invasive ventilation
ivermectin
length of stay
major clinical study
male
middle aged
mortality
noninvasive ventilation
observational study
oxygen
pandemic
remdesivir
retrospective study
sarilumab
Severe acute respiratory syndrome coronavirus 2
tocilizumab
treatment patterns
United States
vitamin D
young adult
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items